Articles Published in 2008

Stay Granted in Muscular Dystrophy Clinical Trial Case

Friday, September 19, 2008 12:38 PM

The U.S. Court of Appeals for the Third Circuit has granted PTC Therapeutics’ request for a stay of the Federal District Court’s decision on August 20 that would have forced the biotech company to provide its experimental drug PTC124 to 16-year-old Duchenne muscular dystrophy patient Jacob Gunvalson outside its clinical trial process.

More... »

MMG Partners With Exco InTouch

Thursday, September 18, 2008 04:45 PM

Global patient recruitment and retention firm MMG has partnered with Exco InTouch to provide mobile messaging services to its sponsor clients. According to the Rockville, Md.-based company, Exco’s mobile technology will enable sponsors to quickly identify and pre-screen potential subjects for clinical studies, as well as provide ongoing contact with patients via mobile messages, reducing the amount of input required from study organizers.

More... »

eTrials Names Permanent CFO

Wednesday, September 17, 2008 04:00 PM

etrials, a Morrisville, NC-based eClinical company, named Joseph (Jay) Trepanier II permanent secretary and CFO, replacing James Clark, who resigned in May. Trepanier had been serving as interim secretary and CFO since May and had previously been etrials’ corporate controller and vice president of finance. etrials is currently in the midst of a CEO search, following the sudden resignation of Eugene Chip” Jennings in July. Vice president of technology Chuck Piccirillo serves as interim CEO.

More... »

CenterWatch Commentary: PharmaNet Down in Rough Seas

Tuesday, September 16, 2008 11:00 AM

The contract research business has always been a bit choppy. Projects from drug sponsors often get delayed or canceled. It’s the nature of contract work. But quarterly results should not be as erratic as what PharmaNet Development Group announced late last week.

More... »

Encorium Names New CEO as Stock Plummets

Monday, September 15, 2008 11:10 AM

Wayne, Pa.-based contract research organization (CRO) Encorium named a new president and CEO Sept. 10, just in time for a heated call with investors after Encorium’s shares were cut in half in less than two days.

More... »

PharmaNet Stock Plunges 60% After Cancellations

Friday, September 12, 2008 11:04 AM

PharmaNet Development Group’s shares plunged more than 60% to less than $10 a share in early morning trading after the contract research organization (CRO) cut its financial guidance for the year. The company expects a loss—instead of the previously predicted profit—following cancellations and postponements of projects by biotech and pharmaceutical companies.

More... »

Eurofins AvTech Names New President

Thursday, September 11, 2008 10:20 AM

Eurofins AvTech Laboratories, a Portage, MI-based contract research organization (CRO), has appointed three senior-level executives to its management team. Dr. Raymond Farmen was named president. Farmen is responsible for general management, technical and profit/loss decisions for the company. He also will provide technical and scientific direction for method development, bioanalytical, product testing and animal health areas. In addition to Farmen, Dr. Steven Weber has joined AvTech’s senior management team as director, Bioanalytical, and Leon Clark, Jr. is director, Animal Health.

More... »

Acurian Offers Performance-based Advertising Contracts

Wednesday, September 10, 2008 02:21 PM

Horsham, Pa.-based Acurian has expanded its patient recruitment services to include advertising-based strategies that reduce risks for their clients. Typically, according to Acurian, pharmaceutical, biotech and medical device companies that rely on patient recruitment companies to create centralized advertising campaigns to enroll patients into research studies have little or no recourse if the advertising campaign fails. Acurian’s advertising services offer sponsors performance-based contracts, with payment based on campaign success. Acurian is currently running two large centralized advertising campaigns under performance-based contracts.

More... »

CenterWatch Monthly September 2008 Issue

Tuesday, September 9, 2008 01:00 PM

Central and Eastern Europe: Growth Opportunities, Growing Pains

More... »

Parexel Completes ClinPhone Acquisition and Cuts Earnings Guidance

Tuesday, September 9, 2008 09:41 AM

Parexel, a global contract research organization (CRO), cut its earnings guidance for its first quarter of fiscal year 2009 and for the full fiscal year, with the successful completion of its acquisition of eClinical trial technology company ClinPhone for about $182 million.

More... »

CenterWatch Data Library



Browse by:


December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs